电话:
+1 877 302 8632
传真:
+1 888 205 9894 (Toll-free)
电子邮件:
orders@antibodies-online.cn

SEMA3G 抗体

(Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))
Has chemorepulsive activities for sympathetic axons.

SEMA3G 抗体 by 适用

Find SEMA3G 抗体 for a variety of species such as anti-Human SEMA3G, anti-Mouse SEMA3G. The species listed below are among those available. Click on a link to go to the corresponding products.

SEMA3G 抗体 by 应用范围

Find SEMA3G 抗体 validated for a specific application such as WB, ELISA, IHC, IHC (p). Some of the available applications are listed below. Click on a link to go to the corresponding products.

SEMA3G 抗体 by 抗体来源

Find SEMA3G 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.

SEMA3G 抗体 by 抗原表位

Find SEMA3G 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

SEMA3G 抗体 by 克隆形成能力

Find available monoclonal or polyclonal SEMA3G 抗体. Click on a link to go to the corresponding products.

SEMA3G 抗体 by 克隆

Find SEMA3G 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.

SEMA3G 抗体 by 标记

Find SEMA3G 抗体 with a specific conjugate such as Biotin, APC, Alkaline Phosphatase (AP). The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular SEMA3G 抗体

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application WB
Validations
  • collections(1)
Cat. No. ABIN1327162
Quantity 100 μg
Reactivity Human
Application WB
Validations
  • collections(1)
Cat. No. ABIN528009
Quantity 50 μg
Reactivity Human
Application ELISA, IHC
Validations
Cat. No. ABIN7001786
Quantity 20 μL
Reactivity Human
Application ELISA, WB
Validations
Cat. No. ABIN7130996
Quantity 100 μL
Reactivity Human, Mouse
Application ELISA
Validations
Cat. No. ABIN7094920
Quantity 100 μL
Reactivity Human
Application IHC, WB
Validations
Cat. No. ABIN2797512
Quantity 400 μL
Reactivity Human
Application ELISA, FACS, IHC, WB
Validations
Cat. No. ABIN6881707
Quantity 100 μL
Reactivity Human
Application WB
Validations
Cat. No. ABIN2357695
Quantity 50 μg
Reactivity Human
Application IHC, ELISA, WB
Validations
Cat. No. ABIN2357610
Quantity 200 μL

Latest Publications on our SEMA3G 抗体

Thal, Züchner, Gierer, Schulte, Schöls, Schüle, Synofzik: "Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation." in: International journal of molecular sciences, Vol. 16, Issue 10, pp. 25050-66, (2016) (PubMed).

Franke, Rickelt, Zimbelmann, Dörflinger, Kuhn, Frey, Heid, Rosin-Arbesfeld et al.: "Striatins as plaque molecules of zonulae adhaerentes in simple epithelia, of tessellate junctions in stratified epithelia, of cardiac composite junctions and of various size classes of lateral ..." in: Cell and tissue research, Vol. 359, Issue 3, pp. 779-97, (2015) (PubMed).

Häggmark, Neiman, Drobin, Zwahlen, Uhlén, Nilsson, Schwenk: "Classification of protein profiles from antibody microarrays using heat and detergent treatment." in: New biotechnology, Vol. 29, Issue 5, pp. 564-70, (2012) (PubMed).

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

Karayan-Tapon, Wager, Guilhot, Levillain, Marquant, Clarhaut, Potiron, Roche: "Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?" in: British journal of cancer, Vol. 99, Issue 7, pp. 1153-60, (2008) (PubMed).

Kigel, Varshavsky, Kessler, Neufeld: "Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells." in: PLoS ONE, Vol. 3, Issue 9, pp. e3287, (2008) (PubMed).

Rikova, Guo, Zeng, Possemato, Yu, Haack, Nardone, Lee, Reeves, Li, Hu, Tan, Stokes, Sullivan, Mitchell, Wetzel, Macneill, Ren, Yuan, Bakalarski, Villen, Kornhauser, Smith, Li, Zhou, Gygi, Gu et al.: "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. ..." in: Cell, Vol. 131, Issue 6, pp. 1190-203, (2007) (PubMed).

Howell, Shindo, Murray, Gridley, Wilson, Schimenti: "Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations." in: Genetics, Vol. 175, Issue 2, pp. 699-707, (2007) (PubMed).

Fukuda, Mikoshiba: "Tac2-N, an atypical C-type tandem C2 protein localized in the nucleus." in: FEBS letters, Vol. 503, Issue 2-3, pp. 217-8, (2001) (PubMed).

Aliases for SEMA3G 抗体

semaphorin 3G (SEMA3G) 抗体
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G (Sema3g) 抗体
semaphorin 3G (Sema3g) 抗体
semaphorin 3G (sema3g) 抗体
AK129018 抗体
CSG53 抗体
RGD1306079 抗体
sem2 抗体
You are here:
help 客服